TABLE 2.
Clinical Characteristics of Patients With Gastric Cancer Who Underwent Elective Gastrectomy
| Pre-regionalization (Feb 2012–Apr 2016) (N = 167) |
Post-regionalization (May 2016–Mar 2023) (N = 386) |
||||
|---|---|---|---|---|---|
| Characteristic | N | % | N | % | P Value |
| Duration of surgery (min) Median |
226 | 239 | 0.044 | ||
| Length of hospital stays(day), Median |
7 | 2 | <0.0001 |
||
| Surgical approach Laparoscopic Open |
29 138 |
17.4 82.6 |
377 9 |
97.7 2.3 |
<0.0001 |
| Type of gastrectomy Subtotal gastrectomy Total gastrectomy |
123 44 |
73.6 26.4 |
303 83 |
78.5 21.5 |
0.213 |
| Extend of lymphadenectomy D2 |
7 | 4.2 | 340 | 88.1 | <0.0001 |
| No. of lymph node dissected. Median |
17 | 40.5 | <0.0001 |
||
| Resection margin R0 |
152 | 91 | 371 | 96.1 | 0.030 |
| ER visit, 30 days |
58 | 34.7 | 76 | 19.7 | 0.0002 |
| Readmission, 30 days |
31 | 18.6 | 43 | 11.1 | 0.019 |
| Reoperation 30 days |
10 | 6 | 26 | 6.7 | 0.745 |
| ICU utilization Yes |
18 | 10.8 | 11 | 2.9 | 0.0001 |
| Mortality, 30 days |
1 | 0.6 | 4 | 1 | 0.618 |
| Post-op chemotherapy received. Yes |
57 | 34.1 | 245 | 63.5 | <0.0001 |
| Time between gastrectomy to restarting chemotherapy (days) Median |
49 |
41 |
0.002 | ||
Kaiser Permanente Northern California, pre- and post-regionalization pathway, Feb 2012 to March 2023.
ICU indicates intensive care unit.